206 related articles for article (PubMed ID: 35902768)
1. Mutant p53 drives an immune cold tumor immune microenvironment in oral squamous cell carcinoma.
Shi Y; Xie T; Wang B; Wang R; Cai Y; Yuan B; Gleber-Netto FO; Tian X; Rodriguez-Rosario AE; Osman AA; Wang J; Pickering CR; Ren X; Sikora AG; Myers JN; Rangel R
Commun Biol; 2022 Jul; 5(1):757. PubMed ID: 35902768
[TBL] [Abstract][Full Text] [Related]
2.
Shi Y; Ren X; Cao S; Chen X; Yuan B; Brasil da Costa FH; Rodriguez Rosario AE; Corona A; Michikawa C; Veeramachaneni R; Osman AA; Xie T; Wang W; Sikora AG; Myers JN; Rangel R
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37604640
[TBL] [Abstract][Full Text] [Related]
3. NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma.
Hamad SH; Sellers RS; Wamsley N; Zolkind P; Schrank TP; Major MB; Weissman BE
Cancer Res Commun; 2024 Feb; 4(2):487-495. PubMed ID: 38335300
[TBL] [Abstract][Full Text] [Related]
4. Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinoma.
Gleber-Netto FO; Neskey D; Costa AFM; Kataria P; Rao X; Wang J; Kowalski LP; Pickering CR; Dias-Neto E; Myers JN
Cancer; 2020 Oct; 126(20):4498-4510. PubMed ID: 32797678
[TBL] [Abstract][Full Text] [Related]
5. Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers.
Chen SMY; Popolizio V; Woolaver RA; Ge H; Krinsky AL; John J; Danis E; Ke Y; Kramer Y; Bian L; Nicklawsky AG; Gao D; Liu S; Chen Z; Wang XJ; Wang JH
J Exp Clin Cancer Res; 2022 Apr; 41(1):123. PubMed ID: 35366939
[TBL] [Abstract][Full Text] [Related]
6. MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment.
Fang DD; Tang Q; Kong Y; Wang Q; Gu J; Fang X; Zou P; Rong T; Wang J; Yang D; Zhai Y
J Immunother Cancer; 2019 Nov; 7(1):327. PubMed ID: 31779710
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
8. Targeting the DNA Damage Response in OSCC with TP53 Mutations.
Lindemann A; Takahashi H; Patel AA; Osman AA; Myers JN
J Dent Res; 2018 Jun; 97(6):635-644. PubMed ID: 29489434
[TBL] [Abstract][Full Text] [Related]
9. Potential for treatment benefit of STING agonists plus immune checkpoint inhibitors in oral squamous cell carcinoma.
Zhu C; Li J; Yao M; Fang C
BMC Oral Health; 2021 Oct; 21(1):506. PubMed ID: 34625078
[TBL] [Abstract][Full Text] [Related]
10. Local Anti-PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model.
Shi Y; Xie TX; Leach DG; Wang B; Young S; Osman AA; Sikora AG; Ren X; Hartgerink JD; Myers JN; Rangel R
Cancer Prev Res (Phila); 2021 Aug; 14(8):767-778. PubMed ID: 34021022
[TBL] [Abstract][Full Text] [Related]
11. The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors.
Tosi A; Parisatto B; Menegaldo A; Spinato G; Guido M; Del Mistro A; Bussani R; Zanconati F; Tofanelli M; Tirelli G; Boscolo-Rizzo P; Rosato A
J Exp Clin Cancer Res; 2022 Sep; 41(1):279. PubMed ID: 36123711
[TBL] [Abstract][Full Text] [Related]
12. Reactivation of p53 by RITA Induces Apoptosis in Human Oral Squamous Cell Carcinoma Cells.
Endo M; Nishioka T; Numazaki K; Hasegawa H; Takahashi T; Sugawara S; Tada H
Anticancer Res; 2022 Jun; 42(6):2931-2937. PubMed ID: 35641264
[TBL] [Abstract][Full Text] [Related]
13. Tumor-related markers in histologically normal margins correlate with locally recurrent oral squamous cell carcinoma: a retrospective study.
Wang X; Chen S; Chen X; Zhang C; Liang X
J Oral Pathol Med; 2016 Feb; 45(2):83-8. PubMed ID: 26260282
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ
Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858
[TBL] [Abstract][Full Text] [Related]
15. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
Front Immunol; 2022; 13():922195. PubMed ID: 35935989
[TBL] [Abstract][Full Text] [Related]
16. ICI-based therapies: A new strategy for oral potentially malignant disorders.
Wang T; Sun S; Zeng X; Li J
Oral Oncol; 2023 May; 140():106388. PubMed ID: 37054586
[TBL] [Abstract][Full Text] [Related]
17. Genomic and Transcriptomic Landscape of an Oral Squamous Cell Carcinoma Mouse Model for Immunotherapy.
Lee YM; Hsu CL; Chen YH; Ou DL; Hsu C; Tan CT
Cancer Immunol Res; 2023 Nov; 11(11):1553-1567. PubMed ID: 37669022
[TBL] [Abstract][Full Text] [Related]
18. Regulation of PD-L1 expression in a high-grade invasive human oral squamous cell carcinoma microenvironment.
Hirai M; Kitahara H; Kobayashi Y; Kato K; Bou-Gharios G; Nakamura H; Kawashiri S
Int J Oncol; 2017 Jan; 50(1):41-48. PubMed ID: 27922697
[TBL] [Abstract][Full Text] [Related]
19. Assessing immuno-expression of p53 protein and TP 53 gene amplification in histologically negative surgical margins of oral squamous cell carcinoma patients and normal oral mucosa.
Kamat MS; Puranik RS; Das Rai AB; Patil BR; Patil S
Clin Oral Investig; 2022 Oct; 26(10):6235-6243. PubMed ID: 35674840
[TBL] [Abstract][Full Text] [Related]
20. The mutational spectrum in whole exon of p53 in oral squamous cell carcinoma and its clinical implications.
Hyodo T; Kuribayashi N; Fukumoto C; Komiyama Y; Shiraishi R; Kamimura R; Sawatani Y; Yaguchi E; Hasegawa T; Izumi S; Wakui T; Nakashiro KI; Uchida D; Kawamata H
Sci Rep; 2022 Dec; 12(1):21695. PubMed ID: 36522371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
